Clinical Report: Delirious Mania Following Cesarean Section in a Bipolar Disorder Patient
Overview
This case study presents a rare instance of postpartum delirious mania in a 27-year-old woman with bipolar disorder type I, following her second cesarean section. The patient exhibited severe symptoms including agitation and psychotic features, which improved significantly after electroconvulsive therapy.
Background
Postpartum psychiatric episodes, particularly in women with bipolar disorder, are critical to recognize due to their potential severity and impact on both mother and child. Delirious mania, characterized by a combination of delirium and manic symptoms, is particularly rare and often underdiagnosed, posing life-threatening risks. Understanding its clinical features and treatment options is essential for timely intervention.
Data Highlights
No numerical data or trial data presented in the article.
Key Findings
The patient developed manic symptoms with psychotic features on the third postoperative day following cesarean section.
Initial treatments with sodium valproate, quetiapine, and propofol were ineffective.
Electroconvulsive therapy (ECT) led to rapid improvement of symptoms.
Post-discharge, the patient remained free of manic or delirious symptoms while on maintenance therapy with olanzapine and sodium valproate.
Women with bipolar disorder may have an increased risk of delirious mania with multiple childbirths.
Clinical Implications
Clinicians should be vigilant for signs of delirious mania in postpartum women with a history of bipolar disorder, especially following cesarean sections. ECT may be a critical treatment option for rapid symptom relief in such cases.
Conclusion
Delirious mania is a rare but serious condition that can occur postpartum in women with bipolar disorder, and effective treatment options like ECT can lead to significant recovery.
Researchers found misinformation rates ranged from 0% to 57% across platforms and topics, with higher rates reported in several TikTok studies compared with YouTube.